Department for Social Sphere, Trade and Non-productive Services
Head of the Department - Ms. Nadezhda Sharavskaya
Deputy Head of the Department - Ms. Yulia Ermakova
Deputy Head of the Department - Ms. Daria Selivanova
Deputy Head of the Department - Ms. Yulia Ermakova
Deputy Head of the Department - Ms. Daria Selivanova
![“Hot line” on violations of the Law on Trade is opened](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/торговля.jpg)
Suppliers, retailers and producers can inform FAS about unlawful actions of their counteragents
more
08.06.2017
Andrey Kashevarov: the remaining misbalance between retailers and suppliers can lead to new amendments to the lawmore
FAS will search options for regulating relations between market participants under remaining misbalance of interests and rights
more
07.06.2017
Ekaterina Uryukina: FAS summarizes enforcement practice that will prevent typical violations of the Law on Trademore![Ekaterina Uryukina: FAS summarizes enforcement practice that will prevent typical violations of the Law on Trade](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/archive/lori-0001430861-bigwww.jpg)
Disclosing information will create conditions for non-discriminatory access of suppliers to retail chain
more
![Appeal Court confirmed legitimacy of FAS acts regarding “Lenta” retailer](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/lori-0023047913-bigwww.jpg)
“Lenta” Ltd. created discriminatory conditions for suppliers of alcohol products
more
![FAS: the health system is not ready for the risk-sharing drug supply systems](/assets/components/gallery/connector.php?action=web/phpthumb&ctx=web&w=123&h=123&zc=1&far=C&q=90&src=/upload/news/lori-0005868896-bigwww_slider.jpg)
The national health care system requires drastic changes in terms of clinical recommendations, interactions between medical doctors and pharmaceutical companies as well as creating a uniform system of implementing and objective evaluation of the efficiency of medicinal drugs under a risk-sharing model
more